Chemical Intermediates for US Pharma from Japan
Active pharmaceutical intermediates imported for final synthesis, crystallization, and formulation into US-manufactured prescription drugs.
Duty Rate — Japan → United States
12.5%
Rate breakdown
9903.05.4912.5%Section 301 (forced labor) — Japan (col1 rate < 12.5 percent): MFN < 12.5% → total duty capped at 12.5%
Import Tips
• Include FDA-approved synthesis routes and batch records proving chemical transformation
• DEA controls apply to controlled substance intermediates regardless of processing
• Finished APIs classify under Chapter 29 or 30 pharmaceutical products